Investor Relations News

  • Holding(s) in Company
    TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Renovo Group plc 2.... read more
  • Notification of Interims
    RENOVO GROUP PLC INTERIM RESULTS NOTIFICATION Renovo Group plc (LSE: RNVO), the biopharmaceutical company developing drugs for the prevention and reduction of scarring at multiple body sites, wil... read more
  • Holding(s) in Company
    TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Renovo Group plc 2.... read more
  • Holding(s) in Company
    TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Renovo Group plc 2.... read more
  • Prevascar Phase II Results
    RENOVO ANNOUNCES POSITIVE PHASE II EFFICACY TRIAL RESULTS FOR PREVASCAR Renovo Group plc (LSE: RNVO), the biopharmaceutical company developing drugs for the prevention and reductio... read more